胃癌患者肿瘤组织中B细胞的浸润及其免疫抑制功能的研究

李雨贤; 段振铨; 王莹; 谭雪玲; 余小红; 张媛媛; 朱宝行; 邱远; 彭六生; 邹全明

doi:10.16016/j.2097-0927.202312006

您当前的位置：

首页 >

文章列表页 >

胃癌患者肿瘤组织中B细胞的浸润及其免疫抑制功能的研究

临床医学 | 更新时间：2026-01-09

- 胃癌患者肿瘤组织中B细胞的浸润及其免疫抑制功能的研究
- Infiltration and immunosuppressive function of tumor-associated B cells in gastric cancer patients
- 陆军军医大学学报 2024年46卷第9期页码：1034-1040
- 作者机构：
  
  1.400038 重庆，陆军军医大学(第三军医大学)药学与检验医学系微生物与生化药学教研室
  2.637000 四川南充，川北医学院附属医院肿瘤科
  3.400037 重庆，陆军军医大学(第三军医大学)第二附属医院普外科
  4.400054 重庆, 重庆理工大学药学院
- 作者简介：
  
  [彭六生，E-mail：pengliusheng06@163.comPENG Liusheng, E-mail: pengliusheng06@163.com
  [邹全明，E-mail：qmzou@tmmu.edu.cnZOU Quanming, E-mail: qmzou@tmmu.edu.cn
- 基金信息：
  
  重庆市自然科学基金面上项目(CSTC2021jcyj-msxmX0579)
- DOI：10.16016/j.2097-0927.202312006
  中图分类号： R392.12;R730.23;R735.2
- 收稿：2023-10-26，
  
  修回：2023-11-24，
  
  纸质出版：2024-05-15
- 稿件说明：
移动端阅览
李雨贤, 段振铨, 王莹, 等. 胃癌患者肿瘤组织中B细胞的浸润及其免疫抑制功能的研究[J]. 陆军军医大学学报, 2024,46(9):1034-1040.

Yuxian LI, Zhenquan DUAN, Ying WANG, et al. Infiltration and immunosuppressive function of tumor-associated B cells in gastric cancer patients[J]. Journal of Army Medical University, 2024, 46(9): 1034-1040.
李雨贤, 段振铨, 王莹, 等. 胃癌患者肿瘤组织中B细胞的浸润及其免疫抑制功能的研究[J]. 陆军军医大学学报, 2024,46(9):1034-1040. DOI： 10.16016/j.2097-0927.202312006.

Yuxian LI, Zhenquan DUAN, Ying WANG, et al. Infiltration and immunosuppressive function of tumor-associated B cells in gastric cancer patients[J]. Journal of Army Medical University, 2024, 46(9): 1034-1040. DOI： 10.16016/j.2097-0927.202312006.

摘要

目的

检测B细胞在胃癌患者肿瘤组织和正常胃组织中的分布

分析其表型特征并探究肿瘤组织来源的B细胞对T细胞增殖的影响。

方法

采用免疫组织化学染色对33例胃癌患者的肿瘤组织和正常胃组织切片进行B细胞表面标志CD19染色并分析其浸润数目，同时采用流式细胞术检测肿瘤组织和正常胃组织中B细胞的趋化因子受体和免疫球蛋白分子表达水平，并通过趋化实验研究CXCL12-CXCR4轴对B细胞的趋化作用，最后分离纯化出肿瘤组织和正常胃组织中的B细胞与自体的外周T细胞共培养，探讨B细胞对T细胞增殖的影响。

结果

胃癌患者肿瘤组织中B细胞的浸润数目显著高于正常胃组织(

＜0.01)；且与正常胃组织来源的B细胞相比，肿瘤组织来源的B细胞高表达趋化因子受体CXCR4(

＜0.05)；TCGA数据库表明胃癌患者肿瘤组织中CXCL12的表达水平与CD19的表达水平呈正相关(

=0.15，

＜0.01)，胃癌患者临床样本的肿瘤组织中CXCL12的表达水平与B细胞浸润数目亦呈正相关(

=0.93，

＜0.05)，趋化实验证实CXCL12-CXCR4轴参与促进B细胞的趋化(

＜0.05)；尽管B细胞在肿瘤组织和正常胃组织中表达的IgM、IgG和IgA相当，但是体外共培养研究显示，与正常胃组织来源的B细胞相比，肿瘤组织来源的B细胞可显著抑制T细胞的增殖(

＜0.01)。

结论

B细胞在胃癌组织中的浸润增加，其可能通过CXCL12-CXCR4轴被募集至肿瘤组织，进而抑制T细胞的增殖以参与促进胃癌的进展。

Abstract

Objective

To investigate the distribution of B cells in both tumor and non-tumor tissues of gastric cancer patients

analyze their phenotypic characteristics and explore the impact on T cell proliferation.

Methods

Immunohistochemical staining was utilized to detect the expression of B cell surface marker CD19 in tumor and non-tumor tissues from 33 gastric cancer patients. The expression levels of chemokine receptors and immunoglobulin molecules on B cells in both tumor and non-tumor tissues were measured using flow cytometry. Chemotaxis experiments were conducted to examine the role of the CXCL12-CXCR4 axis in B cell chemotaxis. B cells isolated and purified from both tissue types were co-cultured with autologous peripheral T cells to assess their effect on T cell proliferation.

Results

There were significantly more B cells infiltrated in tumor tissues than those infitrated in the non-tumor tissues of gastric cancer patients (

0.01)

and CXCR4 was highly expressed on tumor-infiltrating B cells compared with B cells derived from non-tumor tissues (

0.05). The Cancer Genome Atlas (TCGA) analysis indicated that the expression level of CXCL12 in tumor tissues was positively correlated with the expression level of CD19 in gastric cancer patients (

=0.15

0.01). And the expression level of CXCL12 in tumor tissues of the gastric cancer patients was also positively correlated with the number of B cells infiltrated in tumor tissues. Chemotaxis experiments confirmed that the CXCL12-CXCR4 axis was involved in promoting B cell chemotaxis (

0.05). Although B cells in tumor and non-tumor tissues had similar levels of IgM

IgG

and IgA expression

tumor-infiltrating B cells significantly inhibited the proliferation of T cells when compared with B cells derived from non-tumor tissues (

0.01).

Conclusion

There are more B cells infiltrated in gastric cancer tissues

which may be recruited to tumor tissues through the CXCL12-CXCR4 axis

and then inhibit T cell proliferation to promote the progression of gastric cancer.

关键词

Keywords

references

SMYTH E C, NILSSON M, GRABSCH H I, et al . Gastric cancer[J ] . Lancet, 2020, 396(10251): 635-648. DOI: 10.1016/S0140-6736(20)31288-5.

SUNG H, FERLAY J, SIEGEL R L, et al . Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J ] . CA Cancer J Clin, 2021, 71(3): 209-249. DOI: 10.3322/caac.21660.

CAO W, CHEN H D, YU Y W, et al . Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020[J ] . Chin Med J, 2021, 134(7): 783-791. DOI: 10.1097/CM9.0000000000001474.

CHEONG J H, YANG H K, KIM H, et al . Predictive test for chemotherapy response in resectable gastric cancer: a multi-cohort, retrospective analysis[J ] . Lancet Oncol, 2018, 19(5): 629-638. DOI: 10.1016/S1470-2045(18)30108-6.

SASAKO M, SAKURAMOTO S, KATAI H, et al . Five-year outcomes of a randomized phase Ⅲ trial comparing adjuvant chemotherapy with S-1 versus surgery alone in stage Ⅱ or Ⅲ gastric cancer[J ] . J Clin Oncol, 2011, 29(33): 4387-4393. DOI: 10.1200/JCO.2011.36.5908.

O'DONNELL J S, TENG M W L, SMYTH M J. Cancer immunoediting and resistance to T cell-based immunotherapy[J]. Nat Rev Clin Oncol, 2019, 16(3): 151-167. DOI: 10.1038/s41571-018-0142-8.

PAN C X, LIU H T, ROBINS E, et al . Next-generation immuno-oncology agents: current momentum shifts in cancer immunotherapy[J ] . J Hematol Oncol, 2020, 13(1): 29. DOI: 10.1186/s13045-020-00862-w.

PITT J M, MARABELLE A, EGGERMONT A, et al . Targeting the tumor microenvironment: removing obstruction to anticancer immune responses and immunotherapy[J ] . Ann Oncol, 2016, 27(8): 1482-1492. DOI: 10.1093/annonc/mdw168.

DENKERT C, VON MINCKWITZ G, DARB-ESFAHANI S, et al . Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy[J ] . Lancet Oncol, 2018, 19(1): 40-50. DOI: 10.1016/S1470-2045(17)30904-X.

GARAUD S, BUISSERET L, SOLINAS C, et al . Tum or infiltrating B-cells signal functional humoral immune responses in breast cancer[J ] . JCI Insight, 2019, 5(18): e129641. DOI: 10.1172/jci.insight.129641.

CABRITA R, LAUSS M, SANNA A, et al . Tertiary lymphoid structures improve immunotherapy and survival in melanoma[J ] . Nature, 2020, 577(7791): 561-565. DOI: 10.1038/s41586-019-1914-8.

LU Y W, ZHAO Q Y, LIAO J Y, et al . Complement signals determine opposite effects of B cells in chemotherapy-induced immunity[J ] . Cell, 2020, 180(6): 1081-1097.e24. DOI: 10.1016/j.cell.2020.02.015.

GARNELO M, TAN A, HER Z, et al . Interaction between tumour-infiltrating B cells and T cells controls the progression of hepatocellular carcinoma[J ] . Gut, 2017, 66(2): 342-351. DOI: 10.1136/gutjnl-2015-310814.

WEI Y, LAO X M, XIAO X, et al . Plasma cell polarization to the immunoglobulin G phenotype in hepatocellular carcinomas involves epigenetic alterations and promotes hepatoma progression in mice[J ] . Gastroenterology, 2019, 156(6): 1890-1904.e16. DOI: 10.1053/j.gastro.2019.01.250.

BINDEA G, MLECNIK B, TOSOLINI M, et al . Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer[J ] . Immunity, 2013, 39( 4): 782-795. DOI: 10.1016/j.immuni.2013.10.003.

ZHANG S W, WANG B Z, MA F, et al . Characteristics of B lymphocyte infiltration in HPV + head and neck squamous cell carcinoma[J ] . Cancer Sci, 2021, 112(4): 1402-1416. DOI: 10.1111/cas.14834..

NI Z L, XING D, ZHANG T M, et al . Tumor-infiltrating B cell is associated with the control of progression of gastric cancer[J ] . Immunol Res, 2021, 69(1): 43-52. DOI: 10.1007/s12026-020-09167-z.

LIU H F, WU J, XU X Y, et al . Peritumoral TIGIT + CD20 + B cell infiltration indicates poor prognosis but favorable adjuvant chemotherapeutic response in gastric cancer[J ] . Int Immunopharmacol, 2022, 108: 108735. DOI: 10.1016/j.intimp.2022.108735..

CHEN M M, XIAO X, LAO X M, et al . Polarization of tissue-resident TFH-like cells in human hepatoma bridges innate monocyte inflammation and M2b macrophage polarization[J ] . Cancer Discov, 2016, 6(10): 1182-1195. DOI: 10.1158/2159-8290.CD-16-0329.

BISWAS S, MANDAL G, PAYNE K K, et al . IgA transcytosis and antigen recognition govern ovarian cancer immunity[J ] . Nature, 2021, 591(7850): 464-470. DOI: 10.1038/s41586-020-03144-0.

SHALAPOUR S, LIN X J, BASTIAN I N, et al . Inflammation-induced IgA+ cells dismantle anti-liver cancer immunity[J ] . Nature, 2017, 551(7680): 340-345. DOI: 10.1038/nature24302.

PYLAYEVA-GUPTA Y, DAS S, HANDLER J S, et al . IL35-producing B cells promote the development of pancreatic neoplasia[J ] . Cancer Discov, 2016, 6(3): 247-255. DOI: 10.1158/2159-8290.CD-15-0843.

HARRIS R J, WILLSMORE Z, LADDACH R, et al . Enriched circulating and tumor-resident TGF-β + regulatory B cells in patients with melanoma promote FOXP3 + Tregs[J ] . Oncoimmunology, 2022, 11(1): 2104426. DOI: 10.1080/2162402X.2022.2104426..

浏览量

202

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

奥沙利铂通过诱导胃癌细胞铜死亡抑制胃癌

LncRNA FGD5-AS1通过调节miR-302b-3p/E2F1轴对胃癌细胞迁移及侵袭的影响

转录因子TGIF1高表达胃癌的免疫抑制性微环境特征及临床意义分析